Danaher Executive and Leadership Team

November, 2026

Leadership Overview

Danaher has 10 executives leading key functions including information technology, process innovation, financial management, operational oversight, human resources, revenue generation, and technological development.

Focused on advancing global health through scientific innovation, Danaher delivers integrated solutions across biotechnology, life sciences, and diagnostics to accelerate therapeutic development and improve clinical outcomes.

Leadership Roles at Danaher

  • Chief Financial Officer, Sea & Anz, Danaher Corporation - Christine Ying Tan
  • Chief Financial Officer & Vice President, Finance (Beckman Coulter Life Sciences) - Chris Apicerno
  • Chief Financial Officer, , Diagnostics (China) - Hai Harvey Yau
  • Chief Operating Officer of Danaher House - Sharon Danaher
  • Chief Information Officer - Luke Racine
  • Vice President, Execution and Process Excellence, Chief Innovation Office (Chief Information Officer), Danaher Diagnostics - Sarah Kehoe
  • Senior VP & Chief Human Resources Officer - Heathre Moler
  • Chief Revenue Officer, Animal Health - Ronald Rigali
  • Director, Special Projects & Clinical Center of Excellence Chief of Staff - Kristen Warren
  • Chief Technology Officer, CSO (Omics Solutions & Genomic Medicines) - Sadik Kassim
  • Christine Ying Tan - Chief Financial Officer, Sea & Anz, Danaher Corporation

    Christine Ying Tan, the Chief Financial Officer, Sea & Anz, Danaher Corporation at Danaher, manages financial strategy and fiscal health across the Southeast Asia and Australia/New Zealand regions. Tan oversees regional capital allocation, ensuring that investments in biotechnology and life sciences infrastructure align with long-term growth targets. By analyzing market trends in these high-growth territories, the Chief Financial Officer, Sea & Anz, Danaher Corporation supports the expansion of genomic medicine offerings and industrial filtration systems. This leadership role involves collaborating with regional business units to optimize pricing models and cost structures for specialized laboratory equipment. Christine Ying Tan maintains rigorous financial oversight to ensure compliance with local regulations while maximizing profitability. Through strategic financial planning, Tan enables the company to capture emerging opportunities in regional drug development markets. Ultimately, Tan secures the financial stability required for sustained innovation in the Asia-Pacific region.

    Chris Apicerno - Chief Financial Officer & Vice President, Finance (Beckman Coulter Life Sciences)

    Chris Apicerno, the Chief Financial Officer & Vice President, Finance (Beckman Coulter Life Sciences) at Danaher, manages the fiscal strategy for the Beckman Coulter Life Sciences division. Apicerno oversees budgeting, forecasting, and financial reporting for the development of advanced analytical instrumentation and protein purification tools. By analyzing the profitability of specific product lines, the Chief Financial Officer & Vice President, Finance (Beckman Coulter Life Sciences) ensures that resources are allocated to high-impact research and development projects. This leadership role involves collaborating with operational leaders to improve margins on consumables and hardware. Chris Apicerno maintains strict financial controls to support the division's growth in the competitive life sciences market. Through rigorous financial analysis, Apicerno enables the company to scale production of microscopy solutions and genomics platforms. Ultimately, Apicerno secures the financial health required for continuous innovation in laboratory analysis.

    Hai Harvey Yau - Chief Financial Officer, , Diagnostics (China)

    Hai Harvey Yau, the Chief Financial Officer, , Diagnostics (China) at Danaher, manages financial operations and strategic planning for the diagnostics division within the Chinese market. Yau oversees regional fiscal performance, ensuring that investments in clinical diagnostic tools and laboratory equipment align with local market demands. By navigating the complex regulatory and economic landscape, the Chief Financial Officer, , Diagnostics (China) supports the expansion of the company's diagnostic footprint. This leadership role involves optimizing cost structures for the distribution of reagents and analytical instruments across the region. Hai Harvey Yau maintains rigorous financial oversight to ensure compliance with local standards while driving revenue growth. Through strategic financial management, Yau enables the company to capture significant market share in the rapidly evolving Chinese healthcare sector. Ultimately, Yau secures the financial foundation necessary for sustained success in this critical geographic market.

    Sharon Danaher - Chief Operating Officer of Danaher House

    Sharon Danaher, the Chief Operating Officer of Danaher House at Danaher, manages the internal operational framework and facility standards that support the company's global workforce. Danaher oversees the integration of corporate services, ensuring that administrative and physical environments facilitate high-level research and manufacturing activities. By streamlining internal processes, the Chief Operating Officer of Danaher House enhances organizational agility across the biotechnology and diagnostics divisions. This leadership role involves coordinating with department heads to align facility capabilities with the evolving needs of life sciences teams. Sharon Danaher implements operational policies that foster a culture of excellence and safety within all corporate environments. Through the management of shared resources, Danaher optimizes the utilization of specialized equipment and laboratory space. Ultimately, Danaher ensures that the operational backbone of the company remains robust enough to support complex, large-scale therapeutic development projects.
    Sharon Danaher

    Luke Racine - Chief Information Officer

    Luke Racine, the Chief Information Officer at Danaher, directs the digital infrastructure supporting complex biotechnology and diagnostics operations. Racine architects secure, scalable data systems that enable seamless integration across global research and manufacturing facilities. By modernizing enterprise software, the Chief Information Officer ensures that laboratory-scale protein purification tools and analytical instruments remain connected to high-performance computing environments. This leadership role involves mitigating cybersecurity risks while optimizing the flow of critical genomic data across international borders. Luke Racine maintains alignment with the broader corporate strategy by implementing advanced analytics platforms that drive efficiency in drug development workflows. Through the deployment of robust cloud solutions, the Chief Information Officer supports the rapid scaling of manufacturing suites. Ultimately, Racine secures the technological foundation necessary for maintaining market leadership in the competitive life sciences sector.

    Sarah Kehoe - Vice President, Execution and Process Excellence, Chief Innovation Office (Chief Information Officer), Danaher Diagnostics

    Sarah Kehoe, the Vice President, Execution and Process Excellence, Chief Innovation Office (Chief Information Officer), Danaher Diagnostics at Danaher, drives operational rigor within the diagnostics division. Kehoe optimizes complex workflows for clinical diagnostics, ensuring that laboratory analysis tools meet stringent regulatory standards. By implementing lean manufacturing principles, the Vice President, Execution and Process Excellence, Chief Innovation Office (Chief Information Office), Danaher Diagnostics improves the output of specialized equipment and consumables. This leadership role involves coordinating cross-functional teams to accelerate the delivery of diagnostic solutions to healthcare providers. Sarah Kehoe monitors performance metrics to identify bottlenecks in the supply chain, facilitating smoother production cycles for critical reagents and analytical systems. Through continuous improvement initiatives, Kehoe enhances the overall efficiency of the diagnostics portfolio. Ultimately, Kehoe strengthens the company's ability to address urgent clinical challenges through superior process execution.

    Heathre Moler - Senior VP & Chief Human Resources Officer

    Heathre Moler, the Senior VP & Chief Human Resources Officer at Danaher, directs talent acquisition and organizational development strategies across the global enterprise. Moler architects programs that attract top-tier scientists and engineers to support the company's biotechnology and life sciences initiatives. By fostering a high-performance culture, the Senior VP & Chief Human Resources Officer ensures that teams remain aligned with the mission of accelerating therapeutic development. This leadership role involves designing comprehensive training frameworks that keep staff at the forefront of genomics and clinical diagnostics technology. Heathre Moler manages succession planning and leadership development to maintain continuity in critical research and manufacturing functions. Through the implementation of inclusive workplace policies, Moler drives employee engagement and retention. Ultimately, Moler secures the human capital necessary for maintaining the company's competitive edge in the global healthcare market.
    Heathre Moler

    Ronald Rigali - Chief Revenue Officer, Animal Health

    Ronald Rigali, the Chief Revenue Officer, Animal Health at Danaher, drives commercial growth and market penetration for specialized diagnostic and analytical solutions within the animal health sector. Rigali architects sales strategies that expand the reach of mass spectrometers and flow cytometry systems to veterinary research institutions. By identifying new market opportunities, the Chief Revenue Officer, Animal Health ensures that the company's diagnostic tools address the complex needs of animal health practitioners. This leadership role involves managing key client relationships and overseeing the distribution of critical consumables and reagents. Ronald Rigali aligns revenue targets with the broader corporate goal of delivering integrated solutions for therapeutic development. Through the optimization of sales channels, Rigali increases the adoption of advanced genomic medicine offerings. Ultimately, Rigali secures long-term revenue streams by positioning the company as a leader in animal health diagnostics.
    Ronald Rigali

    Kristen Warren - Director, Special Projects & Clinical Center of Excellence Chief of Staff

    Kristen Warren, the Director, Special Projects & Clinical Center of Excellence Chief of Staff at Danaher, coordinates high-priority initiatives within the Clinical Center of Excellence. Warren architects project timelines and resource allocation for cross-functional teams focused on clinical diagnostics and therapeutic manufacturing support. By facilitating communication between the C-suite and technical departments, the Director, Special Projects & Clinical Center of Excellence Chief of Staff ensures that strategic goals remain on track. This leadership role involves managing complex workflows for the development of new diagnostic platforms and healthcare filtration solutions. Kristen Warren monitors project milestones to identify potential risks and implements mitigation strategies to maintain momentum. Through the oversight of special projects, Warren drives the integration of new technologies into the company's existing portfolio. Ultimately, Warren ensures that the Clinical Center of Excellence delivers innovative solutions that meet the evolving needs of global healthcare providers.

    Sadik Kassim - Chief Technology Officer, CSO (Omics Solutions & Genomic Medicines)

    Sadik Kassim, the Chief Technology Officer, CSO (Omics Solutions & Genomic Medicines) at Danaher, directs the research and development of advanced genomic medicine and omics technologies. Kassim architects the technical roadmap for custom nucleic acid products and plasmid DNA manufacturing. By leading innovation in cell culture media and genomic platforms, the Chief Technology Officer, CSO (Omics Solutions & Genomic Medicines) ensures that the company remains at the cutting edge of therapeutic development. This leadership role involves collaborating with scientific teams to translate complex research into scalable manufacturing solutions. Sadik Kassim oversees the integration of new technologies into the company's bioprocess portfolio, enhancing the capabilities of research institutions globally. Through the pursuit of breakthrough scientific advancements, Kassim drives the company's impact on the future of medicine. Ultimately, Kassim secures the technological leadership required to address the most challenging problems in modern biotechnology.
    Sadik Kassim

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding Danaher Top Executives and Leadership Team

    Who leads Danaher?
    Danaher is led by Christine Ying Tan (Chief Financial Officer, Sea & Anz, Danaher Corporation), along with executives such as Chris Apicerno (Chief Financial Officer & Vice President, Finance (Beckman Coulter Life Sciences)) and Hai Harvey Yau (Chief Financial Officer, , Diagnostics (China)).
    Who is part of Danaher’s executive team?
    The executive team of Danaher includes leaders such as Christine Ying Tan (Chief Financial Officer, Sea & Anz, Danaher Corporation), Chris Apicerno (Chief Financial Officer & Vice President, Finance (Beckman Coulter Life Sciences)), Hai Harvey Yau (Chief Financial Officer, , Diagnostics (China)) and other senior executives.
    How many executives does Danaher have?
    Danaher has 10 executives leading key business areas.
    What roles are included in Danaher’s leadership team?
    The leadership team of Danaher includes roles such as Chief Financial Officer, Sea & Anz, Danaher Corporation, Chief Financial Officer & Vice President, Finance (Beckman Coulter Life Sciences), Chief Financial Officer, , Diagnostics (China), Chief Operating Officer of Danaher House, Chief Information Officer.